Www.molecular-modeling.ch Background. For designing, discovering or developing a therapeutically relevant molecule, potency and selectivity to the target.

Slides:



Advertisements
Similar presentations
Module II The Basics of the Brain, the Body and Drug Actions
Advertisements

& the certified athletic trainer
HLTH 340 Lecture A4 Toxicokinetic processes: Distribution (part-1)
Modern Tools for Drug Discovery NIMBUS Biotechnology Modern Tools for Drug Discovery
Improving Candidate Quality Through the Prediction of Clinical Outcome.
Pharmaceutical Medicinal Chemistry-1
Pharmacokinetics (PK) ®The study of the disposition of a drug ®The disposition of a drug includes the processes of ADME -  Absorption  Distribution.
Ionization and dissociation of drugs-1
Lipinski’s rule of five
Principles of Pharmacology. SOURCES AND NAMES OF DRUGS Sources of Drugs Many drugs are isolated from plants or chemically derived from plant substances.
Drug-Like Properties: Optimizing Pharmacokinetics and Safety During Drug Discovery Li Di and Edward H. Kerns ACS Short Course.
Medicinal Chemistry Is the science that deals with the design and development of pharmaceutical agents that has a desired biological effect on human body.
How and Why Drugs Work Chapter 5
Pharmacokinetics (PK): What the body does to the drug? Most drugs: Enter the body by crossing barriers Distributed by the blood to the site of action Biotransform.
Virtual Drug Development in Southern California, A Pre-Clinical Focus in vitro tests to support IND submissions David Johnson, Ph.D. Director, DMPK MicroConstants,
ERT 420 BIOPHARMACEUTICAL ENGINEERING Semester 1 Academic Session 2012/2013 HUZAIRY HASSAN School Of Bioprocess Engineering Universiti Malaysia Perlis.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 2 Drug Action and Handling.
Pharmacology Department
ADME And PHARMACOKINETICS.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
PHARMACOKINETICS.
Concepts and Applications of Pharmacokinetics
Absorption, Distribution, Metabolism and Elimination (ADME)
PHARMACOKINETICS CH. 4 Part 2. GETTING IN ABSORPTION Definition – the movement of a drug from the site of administration into the fluids of the body.
1 Pharmacology Pharmacokinetics –Absorption –Distribution –Biotransformation (metabolism) –Excretion Pharmacodynamics –Receptor binding –Signal transduction.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
Basic Pharmacokinetics The time course of drug action Collected and Prepared By S.Bohlooli, PhD.
Pharmacokinetics of strong opioids Susan Addie Specialist palliative care pharmacist.
Virtual Screening C371 Fall INTRODUCTION Virtual screening – Computational or in silico analog of biological screening –Score, rank, and/or filter.
PHARMACOKINETICS Part 3.
Biopharmaceutics refers to the relationship of the:
CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.
Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy University of Andalas.
!!!……Molecular Target Concept A gonist Antagonist.
PHARMACOKINETICS Definition: quantitative study of drug absorption, distribution, metabolism, and excretion (ADME), and their mathematical relationship.
INTRODUCTION CLINICAL PHARMACOKINETICS
Pharmacology Department
European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.
How and Why Drugs Work Chapter 5. Intended and Unintended Effects of Drugs Intended responses: - Reason for using the drug Unintended responses: - Side.
Principles of Drug Action
PHT 415 BASIC PHARMACOKINETICS
415 PHT Plasma Level – Time Curve
1 CHAPTER 2 DEFINITIONS RELATED TO PHARMACOKINETICS.
By : Dr. Roshini Murugupillai
Julia Salas CS379a Aim of the Study To determine distinguishing features of orally administered drugs –Physical and structural features probed.
Lipinski’s rule of five
Chapter 8 BIOAVAILABILITY & BIOEQUIVALENCE
Pharmacology I BMS 242 Lecture II (Continued)
Medicinal chemistry Third stage Lecture 1
Can Drug Discovery Research be Done At An Undergraduate Institution?
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
BTP 3822 BIOPHARMACEUTICS Quiz I
Pharmaceutics 2.
Pharmacology I BMS 242 Lecture II (Continued)
ADME/Tox PredictionTox Prediction. The characterization of Absorption, Distribution, Metabolism, and Excretion (also known as ADME) and Toxicity are essential.
Biopharmaceutics Dr Mohammad Issa Saleh.
Introduction to Pharmacology
Virtual Screening.
Pharmacokinetics Chapter 4
How and Why Drugs Work Chapter 5
Pharmacokinetics and Factors of Individual Variation
How and Why Drugs Work Chapter 5
1 Concentration-time curve
How and Why Drugs Work Chapter 5
Introduction to Pharmacology
FDA Drug Approval Process
Biopharmaceutics and pharmacokinetic by: Anjam Hama A. M. Sc
Selvadurai Muralidharan, Kalaimani Jaya Raja Kumar
Cheminformatics Basics
How and Why Drugs Work PPT Series 5B
Presentation transcript:

Background. For designing, discovering or developing a therapeutically relevant molecule, potency and selectivity to the target protein is only one side of the problem. Indeed absorption, distribution, metabolism, and excretion (ADME) must be optimized for the molecule to reach its tissue/target in sufficient amount. To reduce off-target and unwanted effects, predictive cheminformatics is recognized as a valid alternative to experimental procedures 1. Objectives. The SwissADME tool gives access through the web to a collection of models for predicting properties of small molecules and hence select the most promising to further study. step 1 (PD) step 2 (PK) step 3 (PD) PHYSICOCHEMICAL DATA Ponatinib has an low TPSA (moderate apparent polarity).  well absorbed by the GI- tract when taken orally.  prone to cross the Blood- Brain Barrier to enter the CNS. PHYSICOCHEMICAL DATA Ponatinib has an low TPSA (moderate apparent polarity).  well absorbed by the GI- tract when taken orally.  prone to cross the Blood- Brain Barrier to enter the CNS. OCTANOL/WATER PARTITION Ponatinib has a high log P (lipophilicity)  oxidation-prone by CYP450.  tendency to be extensively bound to plasma proteins.  Can block hERG-channel. OCTANOL/WATER PARTITION Ponatinib has a high log P (lipophilicity)  oxidation-prone by CYP450.  tendency to be extensively bound to plasma proteins.  Can block hERG-channel. WATER SOLUBILITY Ponatinib is poorly-to- moderately soluble  Potential problems for dose formulation.  Small amount excreted by kidney. WATER SOLUBILITY Ponatinib is poorly-to- moderately soluble  Potential problems for dose formulation.  Small amount excreted by kidney. PHARMACOKINETICS Ponatinib is predicted as:  substrate of P-glycoprotein (efflux from the brain).  Well absorbed by GI-tract (suited for oral administration). PHARMACOKINETICS Ponatinib is predicted as:  substrate of P-glycoprotein (efflux from the brain).  Well absorbed by GI-tract (suited for oral administration). DRUGLIKENESS Ponatinib is considered as a druglike molecule by multiple filters (only size and refractivity are slightly above thresholds).  Suited for oral administration. DRUGLIKENESS Ponatinib is considered as a druglike molecule by multiple filters (only size and refractivity are slightly above thresholds).  Suited for oral administration. CHEMICAL DESCRIPTION Ponatinib is a small molecule (!) CHEMICAL DESCRIPTION Ponatinib is a small molecule (!) MEDICINAL CHEMISTRY Ponatinib returned one alert (triple bound), which is a manageable problematic structural fragment. Ponatinib has a Synthetic Accessibility Score of 3.42 (on a scale from 1 [easy to make] to 10 [very difficult to make]).  Suited for medicinal chemistry and biological screening activities. MEDICINAL CHEMISTRY Ponatinib returned one alert (triple bound), which is a manageable problematic structural fragment. Ponatinib has a Synthetic Accessibility Score of 3.42 (on a scale from 1 [easy to make] to 10 [very difficult to make]).  Suited for medicinal chemistry and biological screening activities. SwissADME